NEW YORK, July 8, 2015 /PRNewswire/ -- Precision for Value (www.precisionforvalue.com), a Precision for Medicine Company which provides health economics, analytics, and marketing communications services to life sciences clients, today announced the further expansion of its Health Economics and Outcomes Research (HEOR) team to meet growing customer demand. Christopher Blanchette, PhD, was appointed Vice President, Health Economics.
Dr. Blanchette is focused on assessing real-world clinical and economic outcomes associated with the use of pharmaceuticals, biologics, and devices. Dr. Blanchette brings over 15 years of experience in evaluating the natural history of chronic diseases, using big data to investigate how healthcare interventions impact clinical and economic outcomes. Before joining Precision, Dr. Blanchette was formerly a Principal and the Americas Leader for the Retrospective Outcomes Research Center of Excellence at IMS Health. He also directed the Division of Clinical and Outcomes Research at the Lovelace Respiratory Research Institute, which included the institute's clinical research, biostatistics, and outcomes research programs. In this capacity he led over 50 employees actively devoted to research in respiratory and related diseases in six sites across the United States.
"We are very pleased to have Chris join our HEOR team at Precision for Value," said Bob Nordyke, PhD, senior vice president, health economics and strategy at Precision for Value. "Chris brings extensive and valuable experience with real-world clinical and economic outcomes. He has a history of successfully mining big data to assess which interventions lead to preferred clinical outcomes, and we look to him build on those abilities to help us grow our HEOR services."
In addition, Dr. Blanchette has served in payer marketing and health economics and outcomes research roles for GlaxoSmithKline, Otsuka America Pharmaceutical Inc., and the Premier Hospital Alliance. He also completed a summer fellowship at the Agency for Healthcare Research and Quality (AHRQ). Dr. Blanchette is a peer reviewer for AHRQ's Health Information Technology Research study section, the Patient-Centered Outcomes Research Institute (PCORI) and many clinical and economics journals. He is the Editor-in-Chief of Drugs in Context and a member of the editorial board for the Journal of Medical Economics and Current Medical Research and Opinion. He is a member of the International Society for Pharmacoeconomics and Outcomes Research, the International Society of Pharmacoepidemiology, the American Thoracic Society, and the American Society for Clinical Oncology.
Dr. Blanchette maintains faculty positions with the Department of Public Health Sciences at the University of North Carolina at Charlotte, the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill, the Erivan K. Haub School of Business at Saint Joseph's University, and the W.G. (Bill) Hefner VA Medical Center.
He has postgraduate training in research management from Duke University, a PhD in Pharmaceutical Health Services Research; an MS in Epidemiology from the University of Maryland Schools of Pharmacy and Medicine; an MBA in Pharmaceutical & Healthcare Marketing from Saint Joseph's University Erivan K. Haub School of Business and a MA in Sociology, as well as a BS in Psychology and BA in History from the University of North Carolina at Charlotte.
About Precision for Value
Precision for Value supports commercial excellence for global pharmaceutical and life sciences clients through the proficient demonstration of product value and outcomes. With locations in New York City, New Jersey, Chicago, Boston, Connecticut, Los Angeles, Oakland and Indianapolis, Precision for Value's teams provide clients with services grounded in decades of industry knowledge, demonstrated analytics proficiency, and marketing and communications prowess -- making Precision for Value the preferred strategic partner in the industry. Visit www.precisionforvalue.com for more information.
About Precision for Medicine
Precision for Medicine is a specialized company providing services and infrastructure to support life sciences companies as they develop new products in the age of precision medicine. Precision brings expertise, technology, and project execution to support innovative, patient-centric solutions from discovery through commercialization. The company is headquartered in Bethesda, MD. Visit www.precisionformedicine.com for more information.
SOURCE Precision for Value